On April 1 2017, Luis Solera will assume the position of CEO of Bioiberica. In his career to date, Luis Solera has held various management positions in the Netherlands, Portugal and Spain. Most recently, he was General Manager of a leading family business in the oils and fats sector. Luis Solera is 47 years old and lives in Barcelona with his wife and two children.
Kurt Stoffel, President of Bioiberica, underlined towards the Bioiberica team and its business partners when the event was announced: “We are convinced that as CEO of Bioiberica, Luis Solera will play a decisive role in shaping the future of Bioiberica and boosting the success of our company, aided by our experienced team and our consolidated market position.”
Bioiberica is a biotechnology company specialising in the identification and extraction of biomolecules of high biological and therapeutic value from tissues of animal origin. It is the leading Western producer of heparin (the world's most commonly used anticoagulant and antithrombotic) and leader in osteoarthritis and joint health for people and animals. Bioiberica is also specialist in the development and production of high-quality ingredients for farm animal feed and natural products to beat plant stress.
They've set up Biovall Heparin Science, a joint pharmaceutical innovation project with an investment of 25 million euros and 20 skilled jobs
Join Bioiberica at stand F130 in Geneva, 9-11 May to discover the company’s latest science and insights driving innovation in the nutraceuticals market.